147 related articles for article (PubMed ID: 35796645)
1. Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study.
de Paula Souza DPS; Dos Reis Pereira Queiroz L; de Souza MG; de Jesus SF; Gomes ESB; Vitorino RT; Santos SHS; Farias LC; de Paula AMB; D'Angelo MFSV; de Carvalho Fraga CA; Guimarães ALS
Oral Dis; 2023 Oct; 29(7):2658-2666. PubMed ID: 35796645
[TBL] [Abstract][Full Text] [Related]
2. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
3. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
4. CXCL8, MMP12, and MMP13 are common biomarkers of periodontitis and oral squamous cell carcinoma.
Chen X; Lei H; Cheng Y; Fang S; Sun W; Zhang X; Jin Z
Oral Dis; 2024 Mar; 30(2):390-407. PubMed ID: 36321868
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
Yue K; Yao X
BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
7. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
9. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma.
Liu DX; Wu KH; Zang XY; Lu JY; Liu MY; Li CM; Gao L
Technol Health Care; 2024; 32(3):1473-1488. PubMed ID: 38073341
[TBL] [Abstract][Full Text] [Related]
12. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
13. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
16. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the expression level of some coding and non-coding genes in oral squamous cell carcinoma.
Ajorlou M; Bina-Jourshari P; Mirzaei S; Maghsoudloo M; Hashemi M; Mousavi-Niri N; Entezari M
Mol Cell Probes; 2023 Aug; 70():101916. PubMed ID: 37355145
[TBL] [Abstract][Full Text] [Related]
19. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
20. Evaluation of the current MicroRNAs expression levels as potential biomarkers in Oral Squamous Cell Carcinoma.
Tahmasebi E; Kaboudanian Ardestani A; Madihi N; Abbasiparashkouh Z; Abbasi Maleki S; Yazdanian M; Khafaei M; Movafagh A; Tavallaie M
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):193-198. PubMed ID: 37114250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]